Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
gastrointestinal-and-intestinal-disorders
Press Release
Mar 9, 2021
Mahana Therapeutics Obtains CE Mark for Parallel™ in the UK
First Prescription Digital Therapeutic to Reduce the Symptom Severity of Irritable Bowel Syndrome Also Receives NICE Recommendation
Read More
Press Release
Dec 8, 2020
Mahana Therapeutics Obtains FDA Marketing Authorization for the First Prescription Digital Therapeutic to Treat Irritable Bowel Syndrome
Company announces industry veteran Steven Basta joining as CEO
Read More
Press Release
Jan 10, 2020
Mahana Therapeutics Enters Into Licensing Agreement With King's College London for Innovative Digital Therapeutic to Treat Gastrointestinal Condition
Psychological-based digital therapy supported by strong clinical data from largest randomized clinical trial of its kind
Read More
Press Release
Jan 10, 2020
Mahana Therapeutics Enters Into Licensing Agreement With King's College London for Innovative Digital Therapeutic to Treat Gastrointestinal Condition
Psychological-based digital therapy supported by strong clinical data from largest randomized clinical trial of its kind
Read More
First
Prev
1
Next
Last
